Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 19.03% is 44% below its 5-year average of 33.68%, near the low end of its 5-year range (1.72%–159.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 50.91% below its 12-month average of 38.76%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.03%.
DEBT TO ASSETS RATIO
19.03%
DEBT TO ASSETS RATIO AVG TTM
38.76%
DEBT TO ASSETS RATIO AVG 3Y
37.22%
DEBT TO ASSETS RATIO AVG 5Y
33.68%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-50.91%
CURRENT VS 3Y AVG
-48.89%
CURRENT VS 5Y AVG
-43.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 589 covered companies
CURRENT VS SECTOR MEDIAN
+18925.04%
vs the sector median at left
Cingulate Inc.
Market Cap
$66.27M
Debt to Assets Ratio
19.03%
TTM Avg
38.76%
3Y Avg
37.22%
5Y Avg
33.68%
Market Cap
$67.43M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$67.67M
Debt to Assets Ratio
0.50%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$64.83M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$64.35M
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $66.27M | 19.03% | 38.76% | 37.22% | 33.68% |
| Fortress Biotech, Inc. (FBIO)vs › | $67.43M | 0.20% | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $67.67M | 0.50% | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $64.83M | 0.01% | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $64.80M | 0.51% | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.35M | 0.59% | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.06M | 0.08% | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $68.60M | 0.02% | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $63.02M | 0.27% | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $70.44M | 0.33% | N/A | N/A | N/A |
Debt/Assets
19.0%
Debt/Equity
0.27
Current Ratio
3.50
Interest Coverage
-21.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 19.03% |
| 2026-03-31 | 24.07% |
| 2025-12-31 | 58.29% |
| 2025-09-30 | 43.53% |
| 2025-06-30 | 48.87% |
| 2025-03-31 | 40.75% |
| 2024-12-31 | 34.30% |
| 2024-09-30 | 1.72% |
| 2024-06-30 | 6.45% |
| 2024-03-31 | 7.70% |
| 2023-12-31 | 100.54% |
| 2023-09-30 | 61.40% |
| 2023-06-30 | 159.68% |
| 2023-03-31 | 80.74% |
| 2022-12-31 | 51.43% |
| 2022-09-30 | 38.67% |
| 2022-06-30 | 5.15% |
| 2022-03-31 | 4.33% |
| 2021-12-31 | 5.14% |
| 2021-09-30 | 15.28% |
| 2021-06-30 | 26.24% |
| 2020-12-31 | 35.36% |
